The benefit of that therapy is that it is conveniently available, economical and simple to provide. Toxic shock syndromes, coronary infarction and cardiac dysrhythmia have been reported [41] Nevertheless, as a result of its lower efficacy as contrasted to oxytocine (in the avoidance of PPH) and to iv sulprostone (in the therapy of PPH), it is only advised in reduced source setups or for therapy in non-severe PPH. Similar to other GPCRs, oxytocin receptors undergo quick molecular desensitisation ...